Astellas Pharma Inc. - Cash and Equivalents

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Cash-and-Equivalents" stands at 215.40 Billion Japanese Yens as of 06/30/2025.

As of the end of Astellas Pharma Inc.'s first quarter, the item "Cash and Equivalents" stands at 215.40 Billion JPY. This represents an increase of 14.35 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -28.89 percent compared to the value the year prior.
The 1 year change in percent is -28.89.
The 3 year change in percent is -31.19.
The 5 year change in percent is -10.23.
The 10 year change in percent is -42.02.

The Serie's long term average value is 300.42 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 28.30 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2010, to it's latest available value, on 06/30/2025, is +53.26%.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 06/30/2025, is -61.64%.